Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

TGF-β signaling in the kidney: profibrotic and protective effects
Angara Sureshbabu, Saif A. Muhsin, Mary E. Choi
AJP Renal Physiology (2016) Vol. 310, Iss. 7, pp. F596-F606
Open Access | Times Cited: 227

Showing 1-25 of 227 citing articles:

New insights into TGF-β/Smad signaling in tissue fibrosis
He-He Hu, Dan‐Qian Chen, Yanni Wang, et al.
Chemico-Biological Interactions (2018) Vol. 292, pp. 76-83
Open Access | Times Cited: 900
Cellular and molecular mechanisms of kidney fibrosis
Sonja Djudjaj, Peter Boor
Molecular Aspects of Medicine (2018) Vol. 65, pp. 16-36
Closed Access | Times Cited: 382
Central role of dysregulation of TGF-β/Smad in CKD progression and potential targets of its treatment
Lin Chen, Tian Yang, Dewen Lu, et al.
Biomedicine & Pharmacotherapy (2018) Vol. 101, pp. 670-681
Open Access | Times Cited: 296
Thrombospondin-1 regulation of latent TGF-β activation: A therapeutic target for fibrotic disease
Joanne E. Murphy-Ullrich, Mark J. Suto
Matrix Biology (2017) Vol. 68-69, pp. 28-43
Open Access | Times Cited: 247
Diverse Role of TGF-β in Kidney Disease
Yue-Yu Gu, Xusheng Liu, Xiao‐Ru Huang, et al.
Frontiers in Cell and Developmental Biology (2020) Vol. 8
Open Access | Times Cited: 191
A Klotho-derived peptide protects against kidney fibrosis by targeting TGF-β signaling
Qian Yuan, Qian Ren, Li Li, et al.
Nature Communications (2022) Vol. 13, Iss. 1
Open Access | Times Cited: 105
Up-Date on Diabetic Nephropathy
Maria Chiara Pelle, Michele Provenzano, Marco Busutti, et al.
Life (2022) Vol. 12, Iss. 8, pp. 1202-1202
Open Access | Times Cited: 72
Obstructive nephropathy and molecular pathophysiology of renal interstitial fibrosis
Rikke Nørregaard, Henricus A. M. Mutsaers, Jørgen Frøkiær, et al.
Physiological Reviews (2023) Vol. 103, Iss. 4, pp. 2847-2892
Open Access | Times Cited: 54
LRG1 Promotes Diabetic Kidney Disease Progression by Enhancing TGF-β–Induced Angiogenesis
Quan Hong, Lu Zhang, Jia Fu, et al.
Journal of the American Society of Nephrology (2019) Vol. 30, Iss. 4, pp. 546-562
Open Access | Times Cited: 118
Transforming Growth Factor-Beta1 in Diabetic Kidney Disease
Lijun Zhao, Yutong Zou, Fang Liu
Frontiers in Cell and Developmental Biology (2020) Vol. 8
Open Access | Times Cited: 115
Dapagliflozin, a sodium‐glucose co‐transporter‐2 inhibitor, slows the progression of renal complications through the suppression of renal inflammation, endoplasmic reticulum stress and apoptosis in prediabetic rats
Krit Jaikumkao, Anchalee Pongchaidecha, Nuttawud Chueakula, et al.
Diabetes Obesity and Metabolism (2018) Vol. 20, Iss. 11, pp. 2617-2626
Closed Access | Times Cited: 91
Thrombospondin 1 and Its Diverse Roles as a Regulator of Extracellular Matrix in Fibrotic Disease
Joanne E. Murphy-Ullrich
Journal of Histochemistry & Cytochemistry (2019) Vol. 67, Iss. 9, pp. 683-699
Open Access | Times Cited: 79
Recent Insights Into SREBP as a Direct Mediator of Kidney Fibrosis via Lipid-Independent Pathways
Debra Dorotea, Daisuke Koya, Hunjoo Ha
Frontiers in Pharmacology (2020) Vol. 11
Open Access | Times Cited: 74
TGF-β/Smad Signaling Pathway in Tubulointerstitial Fibrosis
Xiao-Yong Yu, Qian Sun, Yamei Zhang, et al.
Frontiers in Pharmacology (2022) Vol. 13
Open Access | Times Cited: 53
Targeting endogenous kidney regeneration using anti-IL11 therapy in acute and chronic models of kidney disease
Anissa A. Widjaja, Sivakumar Viswanathan, Shamini G. Shekeran, et al.
Nature Communications (2022) Vol. 13, Iss. 1
Open Access | Times Cited: 43
Intrinsic TGF-β signaling attenuates proximal tubule mitochondrial injury and inflammation in chronic kidney disease
Merve Kayhan, Judith Vouillamoz, Daymé González Rodríguez, et al.
Nature Communications (2023) Vol. 14, Iss. 1
Open Access | Times Cited: 35
Evidence of a causal and modifiable relationship between kidney function and circulating trimethylamine N-oxide
Petros Andrikopoulos, Judith Aron‐Wisnewsky, Rima Chakaroun, et al.
Nature Communications (2023) Vol. 14, Iss. 1
Open Access | Times Cited: 26
Complement activation and cellular inflammation in Fabry disease patients despite enzyme replacement therapy
Björn Laffer, Malte Lenders, Elvira Ehlers-Jeske, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 11
Biomedicine and pharmacotherapeutic effectiveness of combinatorial atorvastatin and quercetin on diabetic nephropathy: An in vitro study
Haleema Shahin DH, Rokeya Sultana, Ashwini Prabhu, et al.
Biomedicine & Pharmacotherapy (2024) Vol. 174, pp. 116533-116533
Open Access | Times Cited: 9
TMAO enhances TNF-α mediated fibrosis and release of inflammatory mediators from renal fibroblasts
Kapetanaki Stefania, Kumawat Kumar Ashok, Paramel Varghese Geena, et al.
Scientific Reports (2024) Vol. 14, Iss. 1
Open Access | Times Cited: 9
Targeting Macrophage Polarization for Reinstating Homeostasis following Tissue Damage
Qiran Du, Anna Dickinson, Pruthvi Nakuleswaran, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 13, pp. 7278-7278
Open Access | Times Cited: 9
METTL3 Potentiates M2 Macrophage‐Driven MMT to Aggravate Renal Allograft Fibrosis via the TGF‐β1/Smad3 Pathway
Qinfan Yao, Xiaoxiao Zheng, Xinyi Zhang, et al.
Advanced Science (2025)
Open Access | Times Cited: 1
A kidney organoid-based readout to assess disease activity in primary and recurrent focal segmental glomerulosclerosis
Ashwani Gupta, Ekta Minocha, Kyle M. Koss, et al.
Kidney International (2025)
Open Access | Times Cited: 1
Progress of ADAM17 in Fibrosis‐Related Diseases
Suyan Yan, Yaqi Zhao, Ya‐Chien Yang, et al.
Mediators of Inflammation (2025) Vol. 2025, Iss. 1
Open Access | Times Cited: 1
Redirecting TGF-β Signaling through the β-Catenin/Foxo Complex Prevents Kidney Fibrosis
Xi Qiao, Padmashree Rao, Yun Zhang, et al.
Journal of the American Society of Nephrology (2017) Vol. 29, Iss. 2, pp. 557-570
Open Access | Times Cited: 65
Page 1 - Next Page

Scroll to top